Phase II randomized study of oral uracil/tegafur (UFT) plus leucovorin (LV) or parenteral 5-Fluorouracil (5-FU) plus leucovorin in patients with metastatic colorectal cancer (MCRC)

被引：0
|
作者：
Sizer, B. [2 ]
Makris, A. [1 ]
Barone, C. [3 ]
Bordonaro, R. [4 ]
Hausmaninger, H. [5 ]
Steger, G. [6 ]
Aloe, A. [7 ]
Peeters, O. [7 ]
Donato, B. [7 ]
机构：
[1] Mt Vernon Hosp, Northwood HA6 2RN, Middx, England
[2] Essex Cty Hosp, Colchester, Essex, England
[3] Univ Cattolica, Rome, Italy
[4] Osped S Luigi, Catania, Italy
[5] Salzburg Hosp, Salzburg, Austria
[6] Med Univ, Vienna, Austria
[7] Bristol Myers Squibb Pharmaceut Res Inst, Braine Lalleud, Belgium
来源：
ANNALS OF ONCOLOGY | 2004年 / 15卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：93 / 93
页数：1
相关论文
共 50 条
  • [1] Oral uracil/tegafur (UFT) plus leucovorin (LV) in patients with metastatic colorectal cancer (CRC)
    Goker, E
    Aykan, NF
    Serdengecti, S
    Gunel, N
    Alakavuklar, M
    Icli, F
    Yucel, I
    Uskent, N
    Arpaci, F
    Firat, D
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S78 - S78
  • [2] Oral doxifluridine plus leucovorin in metastatic colorectal cancer - Randomized phase II trial with intravenous 5-fluorouracil plus leucovorin
    Ahn, JH
    Kim, TW
    Lee, JH
    Min, YJ
    Kim, JG
    Kim, JC
    Yu, CS
    Kim, WK
    Kang, YK
    Lee, JS
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2003, 26 (01): : 98 - 102
  • [3] Phase II study of irinotecan, leucovorin, 5-fluorouracil and tegafur/uracil for metastatic colorectal cancer
    Kono, T
    Ebisawa, Y
    Tomita, I
    Chisato, N
    Kamiya, K
    Asama, T
    Ayabe, T
    Ashida, T
    Kohgo, Y
    Kasai, S
    JOURNAL OF CHEMOTHERAPY, 2005, 17 (02) : 224 - 227
  • [4] Phase II trial of 5-fluorouracil (5FU)/leucovorin (LV), irinotecan, and oxaliplatin (FOLFOXIRI) plus cetuximab in patients with metastatic colorectal cancer (mCRC).
    Sougklakos, I.
    Vardakis, N. K.
    Kampouraki, E.
    Kotortsi, I.
    Androulakis, N. E. M.
    Vamvakas, L.
    Kalbakis, K.
    Hatzidaki, D.
    Mavroudis, D.
    Georgoulias, V.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [5] A phase I study of oral uracil/tegafur (UFT) plus leucovorin (LV) combined with oxaliplatin in patients with metastatic colorectal cancer (CRC).
    Douillard, JY
    Dissoubray, C
    Seitz, JF
    CLINICAL CANCER RESEARCH, 2000, 6 : 4574S - 4574S
  • [6] A multicenter phase II trial of bi-weekly irinotecan (CPT11), infusional 5-fluorouracil (5FU) and leucovorin (LV) with oral tegafur/uracil (UFT) for metastatic colorectal cancer (MCRC).
    Kono, T
    Tomita, I
    Kasai, S
    Chisato, N
    Asama, T
    Kamiya, K
    Yamamoto, Y
    Kawabata, N
    Lhara, M
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 285S - 285S
  • [7] Phase II study of sequential cisplatin plus 5-fluorouracil/leucovorin (5-FU/LV) followed by irinotecan plus 5-FU/LV followed by docetaxel plus 5-FU/LV in patients with metastatic gastric or gastro-oesophageal junction adenocarcinoma
    Fotios Loupakis
    Gianluca Masi
    Lorenzo Fornaro
    Enrico Vasile
    Giacomo Allegrini
    Eloise Fontana
    Cristina Granetto
    Lisa Salvatore
    Lucia Mentuccia
    Michele Andreuccetti
    Enrico Cortesi
    Marco Merlano
    Stefano Cascinu
    Alfredo Falcone
    Cancer Chemotherapy and Pharmacology, 2010, 66 : 559 - 566
  • [8] Phase II study of sequential cisplatin plus 5-fluorouracil/leucovorin (5-FU/LV) followed by irinotecan plus 5-FU/LV followed by docetaxel plus 5-FU/LV in patients with metastatic gastric or gastro-oesophageal junction adenocarcinoma
    Loupakis, Fotios
    Masi, Gianluca
    Fornaro, Lorenzo
    Vasile, Enrico
    Allegrini, Giacomo
    Fontana, Eloise
    Granetto, Cristina
    Salvatore, Lisa
    Mentuccia, Lucia
    Andreuccetti, Michele
    Cortesi, Enrico
    Merlano, Marco
    Cascinu, Stefano
    Falcone, Alfredo
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2010, 66 (03) : 559 - 566
  • [9] 5-Fluorouracil (5-FU) plus leucovorin versus 5-FU leucovorin plus interferon-A given as adjuvant chemotherapy in colon cancer
    Papacostas, P
    Stathopoulos, GP
    Malamos, NA
    Michailakis, E
    Rigatos, S
    Golematis, B
    EUROPEAN JOURNAL OF CANCER, 1995, 31A : 752 - 752
  • [10] Randomized comparative study of tegafur/uracil and oral leucovorin versus parenteral fluorouracil and leucovorin in patients with previously untreated metastatic colorectal cancer
    Carmichael, J
    Popiela, T
    Radstone, D
    Falk, S
    Borner, M
    Oza, A
    Skovsgaard, T
    Munier, S
    Martin, C
    JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (17) : 3617 - 3627
12345